Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of HSK16149 in Chinese Patients With DPNP
NCT04647773Phase 3Unknown
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Dec 2020
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of crisugabalin besilate in diabetic polyneuropathy (DPN), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Status: unknown.
02
Drugs
crisugabalin besilate
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT04647773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04647773.